These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21063786)

  • 1. EuroQol (EQ-5D) health utility scores for patients with migraine.
    Xu R; Insinga RP; Golden W; Hu XH
    Qual Life Res; 2011 May; 20(4):601-8. PubMed ID: 21063786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping from disease-specific measures to health-state utility values in individuals with migraine.
    Gillard PJ; Devine B; Varon SF; Liu L; Sullivan SD
    Value Health; 2012 May; 15(3):485-94. PubMed ID: 22583459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs.
    Stafford MR; Hareendran A; Ng-Mak DS; Insinga RP; Xu R; Stull DE
    Health Qual Life Outcomes; 2012 Jun; 10():65. PubMed ID: 22691697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant.
    Johnston KM; L'Italien G; Popoff E; Powell L; Croop R; Thiry A; Harris L; Coric V; Lipton RB
    Adv Ther; 2021 Oct; 38(10):5209-5220. PubMed ID: 34455556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
    Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
    Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.
    Ahmed F; Gaul C; García-Moncó JC; Sommer K; Martelletti P;
    J Headache Pain; 2019 Mar; 20(1):26. PubMed ID: 30845917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, controlled trial of telcagepant over four migraine attacks.
    Ho AP; Dahlöf CG; Silberstein SD; Saper JR; Ashina M; Kost JT; Froman S; Leibensperger H; Lines CR; Ho TW
    Cephalalgia; 2010 Dec; 30(12):1443-57. PubMed ID: 20974601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
    Ho TW; Ho AP; Chaitman BR; Johnson C; Mathew NT; Kost J; Fan X; Aurora SK; Brandes JL; Fei K; Beebe L; Lines C; Krucoff MW
    Headache; 2012 Feb; 52(2):224-35. PubMed ID: 22221076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
    Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
    Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis.
    Pickard AS; Gooderham M; Hartz S; Nicolay C
    J Med Econ; 2017 Jan; 20(1):19-27. PubMed ID: 27471948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
    Rowen D; Young T; Brazier J; Gaugris S
    Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
    Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
    Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
    Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
    Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild.
    Klapper J; Lucas C; Røsjø Ø; Charlesworth B;
    Cephalalgia; 2004 Nov; 24(11):918-24. PubMed ID: 15482352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, placebo-controlled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe.
    Cady R; Elkind A; Goldstein J; Keywood C
    Curr Med Res Opin; 2004 Sep; 20(9):1465-72. PubMed ID: 15383196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.